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1. Introduction 
The antibiotic pulvomycin has been shown to be 
related to kirromycin with respect to its structure and 
function [l] . Pulvomycin resembles the 5’-substituent 
of the tetrahydrofuran moiety of kirromycin [l] . 
Both antibiotics inhibit prokaryotic protein synthesis 
by virtue of their specific interaction with elongation 
factor Tu [ 1,2] . Since pulvomycin is known to be 
cytotoxic against malignant cells in tissue culture and 
against cells of the ascitic form of Ehrlich carcinoma 
‘(ECA) in mice [3,4] , studies were undertaken to 
determine the effect of both pulvomycin and kirro- 
mycin on macromolecular syntheses in eukaryotic 
systems. 
2. Materials and methods 
ECA cells were propagated in mice by weekly 
intraperitoneal transfer. These mice were a gift of 
H. Probst (Ttibingen). The human cell line studied 
was HeLa, strain S3; the cultured cells were a gift of 
0. G. Issinger (Stuttgart). Radiochemicals were 
purchased from Amersham Buchler (Braunschweig). 
Macromolecular syntheses in ECA and HeLa cells 
were performed as in [5] . Cells (3 X 106) in 3 ml 
phosphate-buffered saline [6] containing 0.6 mg 
heparin (Serva) were incubated with the antibiotics 
for 10 min at 37°C. The cell suspension was then 
transferred to a tube containing 0.1 ,uCi [‘“Cl- 
thymidine (61 Ci/mol), 0.1 PCi [ 14C] uridine 
(53 Ci/mol), or 0.1 j_Zi [14C]leucine (59 Ci/mol). 
After 20 min at 37°C the cells were centrifuged, 
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suspended in trichloroacetic acid (5%), and collected 
on cellulose nitrate filters. The filters were dried and 
the radioactivity was measured. 
Extracts of ECA and wheat embryo cells (KeimdiCt 
GmbH, Augsburg) for polypeptide synthesis were 
prepared as in [7] . Material of low molecular weight 
was removed from the 30 000 X g supernatant by 
Sephadex G-25 filtration. Polyphenylalanine synthesis 
was performed as in [7] . 
Pulvomycin (mol. wt 438) was isolated from 
Streptoverticillium mobaraerlse Tii 1063 according 
to [8] , and kirromycin (mol. wt 796) from Strepto- 
myces collinus Tii 365 as in [9] . 
3. Results and discussion 
The effect of either antibiotic on DNA, RNA, and 
protein synthesis was tested in intact ECA and HeLa 
cells. Figure 1 and fig.2 show that pulvomycin and 
kirromycin reduced uridine incorporation and, to a 
lesser degree, thymidine incorporation in ECA cells, 
whereas the rate of leucine incorporation remained 
unchanged during 30 min incubation; 50% inhibition 
of uridine incorporation into acid-insoluble material 
was observed at 3 X 10” M pulvomycin and 
1 X lo-’ M kirromycin, respectively. In kinetic 
studies, a constant rate of inhibition of uridine 
incorporation was observed after 3 min incubation 
time. 
Similar results were obtained with HeLa cells 
(data not shown). Thus, the pronounced effect of 
these antibiotics on eukaryotic cells might be due to 
an inhibition of RNA synthesis. 
The effect of either antibiotic on poly(U)-directed 
polyphenylalanine synthesis in cell-free extracts of 
189 
Volume 96, number 1 FEBS LETTERS December 1978 
-7 -6 -5 -4 
Log M [pulvomycin] 
Fig.1. Effect of pulvomycin on macromolecular syntheses 
in Ehriich carcinoma ascites cells (me-) protein synthesis; 
(-A-) DNA synthesis: (-¤-) RNA synthesis. 
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F1g.2. Effect of klrromycin on rnacromolecLil~r syntheses 
in Ehrlich carcinoma ascltes cells: (-•-) protein synthesis; 
(-A.-) DNA synthesis; (-m-j RNA synthesis. 
Table 1 
Effect of pulvomycin and kirromycin on polyphenylalanlne synthesis in a cell-free 
system of ECA and wheat embryo cells 
__~ 
Additions 
Control 
~ PO&(U) 
Chloramphenicol 
Cyctohesimlde 
Pulvomycin 
Pulvomycin 
Pulvomycin 
Kirromycin 
Kirromycin 
Kirromycin 
~~ 
Phenylalanine mcorporated (pmol) 
--.____II_ 
Cont. (M) ECA Wheat embryo 
.- 
16.4 14.3 
0.5 1.9 
6x low4 13.0 12.5 
7 x 1o-5 4.1 7.6 
2x 10-e 15.8 13.8 
2 x 10-s 15.2 13.6 
2x 10-d 12.8 13.2 
2 x 10-s 15.1 13.9 
2x 10-S 14.5 13.9 
2x 10-e 13.0 13.4 
Reaction mixtures contained in 100 ~1 50 mM Tris.HCL (pH 7.6). 80 mM KCl, 
10 mM MgCl,, 5 mM dithioerythritol, 1 mM ATP, 0.1 mM GTP, 1 mM creatinc 
phosphate. 8 erg creatine kinase, 0.5 mg tRNA (yeast), 100 pmol [ “C]phenyl- 
alanine (0.2 tiCi), 20 @g poly(Uf, 2 ~1 methanol containing pulvomycin or kirro- 
mycin as indicated, and 10 irl ECA extract or wheat embryo cells. After 15 mm at 
37”C, the radioactivity incorporated into hot 53 trichloroacetic acid-insoluble 
protein was determined 
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ECA and wheat embryo cells was examined. The data 
represented in table 1 support the findings of the 
in vivo experiments. Except for a slight inhibition 
probably due to a contamination of the cytoplasmic 
protein-synthesizing system by the mitochondrial 
system, at up to 1 X lo4 M, both antibiotics did not 
interfere with this reaction. 
Our results indicate that the action of pulvomycin 
and kirromycin on eukaryotic cells is different from 
that on prokaryotic cells. The antibiotics inhibit 
bacterial protein synthesis by acting on elongation 
factor Tu [l] . They do not interfere with RNA and 
DNA synthesis in bacteria in vivo [8,10] and in vitro 
(data not shown). In contrast, the cytotoxic effect 
of either drug on transformed eukaryotic cells might 
be due to an inhibition of RNA synthesis. Low 
toxicity of pulvomycin [ 1 l] and kirromycin [ 121 sug- 
gest a different sensitivity of normal and transformed 
cells. 
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